Figure 6.
Effect of paclitaxel (PTX) concentration (mg/mL) on the (a) HSA-NP size (mean ± SD, n = 10), represented as columns, and polydispersity index, represented as line; (b) zeta potential of HSA-NPs (mean ± SD, n = 10), represented as columns, prepared from a 10 mg/mL starting HSA concentration, a 3% v/v CHCl3-EtOH concentration, 20,000 psi homogenization pressure and 12 cycles of homogenization (*** p < 0.0001).